(Q53531177)

15 May 2018

title

Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. (English)

1 reference

15 May 2018

author name string

Lin Chen

1

1 reference

15 May 2018

Feihu Chu

2

1 reference

15 May 2018

Yali Cao

3

1 reference

15 May 2018

Jianguo Shao

4

1 reference

15 May 2018

Feng Wang

5

1 reference

15 May 2018

publication date

24 April 2015

1 reference

15 May 2018

published in

Tumor Biology

1 reference

15 May 2018

volume

36

1 reference

15 May 2018

issue

10

1 reference

15 May 2018

page(s)

7439-7447

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-3430-2

exact match

0 references

cites work

Hepatocellular carcinoma: clinical frontiers and perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Hepatocellular carcinoma review: current treatment, and evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

MicroRNAs and cancer; an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Tumor-associated circulating microRNAs as biomarkers of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

miR-331-3p regulates expression of neuropilin-2 in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3430-2

Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Serum microRNAs: A new diagnostic method for colorectal cancer

1 reference

12 December 2020

Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer

1 reference

12 December 2020

10.1007/S13277-015-3430-2

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

25903466

1 reference

15 May 2018